Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects
Authors
Keywords
-
Journal
NMR IN BIOMEDICINE
Volume 24, Issue 5, Pages 473-482
Publisher
Wiley
Online
2010-12-08
DOI
10.1002/nbm.1611
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma
- (2010) Keith T. Flaherty et al. CANCER BIOLOGY & THERAPY
- Sorafenib exerts anti-glioma activity in vitro and in vivo
- (2010) Markus D. Siegelin et al. NEUROSCIENCE LETTERS
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- Primetime for antiangiogenic therapy
- (2009) Ghazaleh Tabatabai et al. CURRENT OPINION IN NEUROLOGY
- Dynamic MRI Using Iron Oxide Nanoparticles to Assess Early Vascular Effects of Antiangiogenic versus Corticosteroid Treatment in a Glioma Model
- (2009) Csanad G Varallyay et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Characterization of Tumor Angiogenesis in Rat Brain Using Iron-Based Vessel Size Index MRI in Combination with Gadolinium-Based Dynamic Contrast-Enhanced MRI
- (2009) Marine Beaumont et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging
- (2009) Stefan Zwick et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI
- (2009) M.M. Pike et al. MAGNETIC RESONANCE IN MEDICINE
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Bevacizumab and chemotherapy for recurrent glioblastoma: A single-institution experience
- (2009) P. L. Nghiemphu et al. NEUROLOGY
- Neuroimaging in neuro-oncology
- (2009) Soonmee Cha Neurotherapeutics
- MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium
- (2008) Alexis Jacquier et al. Contrast Media & Molecular Imaging
- Emerging antiangiogenic treatments for gliomas – efficacy and safety issues
- (2008) Jörg Dietrich et al. CURRENT OPINION IN NEUROLOGY
- Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas
- (2008) F. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinalin vivoandex vivostudy
- (2008) Samuel Valable et al. NMR IN BIOMEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now